drugset / Trial / NCT05864885
Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic Alopecia
Phase 1
Unknown
14 enrolled
Aneira Pharma, Inc.
DataPharm Australia, CMAX Clinical Research, Agilex Australia · collab
NaSingle-groupOpen-labelTreatment
Summary
This study will be a single center, open-label study of a single concentration of ANR- 001.1. The solution will be applied to the scalp of 14 male subjects by study staff once daily for 7 days.
Timeline
- Start
- 2023-06-09
- Primary completion
- 2023-07-17
- Completion
- 2023-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Minoxidil | Small molecule | — | Topical |